• Martin Sívori, Alejandra González, Fernando Saldarini, Alejandro Martinez Fraga, Jaime Segovia, Pamela Rossi, Mauro Andreu, Florencia Trullas, and Grupo De Estudio Secuelar 19.
• Unidad de Neumotisiología, Hospital Ramos Mejía, Buenos Aires, Argentina. E-mail: sivorimartin@yahoo.com.
• Medicina (B Aires). 2022 Jan 1; 82 (5): 673-683.

IntroductionThere is scarce information about middle-term evolution of hospitalized patients who suffer from pneumonia caused by COVID-19. The objective of this study is to determine the clinical, respiratory, tomographic and functional impact on COVID-19 patients with moderate (MP) to severe (SP) pneumonia after six months of acute infection.MethodsAnalysis was carried out by MP and SP groups, desaturators during the 6-minute-walking test and the presence of fibrotic like pattern on HRCT. Outcomes at 3 and 6 months were compared.ResultsThe analysis included 129 patients, between 57 ± 11 years old. Frequent comorbidities were: arterial hypertension 38.1%, diabetes 30.4%, respiratory 18.6%). Comparing 3 and 6 months, improvement in quality of life was observed in MP and SP. The DP walked less meters in the MWT, worsened life quality and more fibrotic like pattern. The fibrotic pattern was related to the fall of CVF < 80% on MP and SP (p = 0.048 and p = 0.007), and with DP (p = 0.002). On multivariated analysis, the fibrotic like pattern was associated to the reduction of CVF with OR = 4.44 (1.94-10.18, p <0.01) and desaturation OR = 5.01(1.63-15.42, p < 0.01). On this cohort it was observed more functional and tomographic compromise on the DP The fibrotic like pattern was related to worse functional evolution and oximetry.DiscussionFollow-up after discharge of COVID-19 patients with SP, DP or fibrotic changes in HCRT is underlined.

12 keywords...

hide…